1. Home
  2. ASMB vs KOPN Comparison

ASMB vs KOPN Comparison

Compare ASMB & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • KOPN
  • Stock Information
  • Founded
  • ASMB 2005
  • KOPN 1984
  • Country
  • ASMB United States
  • KOPN United States
  • Employees
  • ASMB N/A
  • KOPN N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • ASMB Health Care
  • KOPN Technology
  • Exchange
  • ASMB Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • ASMB 92.1M
  • KOPN 85.7M
  • IPO Year
  • ASMB 2010
  • KOPN 1992
  • Fundamental
  • Price
  • ASMB $14.82
  • KOPN $2.10
  • Analyst Decision
  • ASMB Buy
  • KOPN Strong Buy
  • Analyst Count
  • ASMB 2
  • KOPN 4
  • Target Price
  • ASMB $35.00
  • KOPN $2.50
  • AVG Volume (30 Days)
  • ASMB 32.6K
  • KOPN 7.0M
  • Earning Date
  • ASMB 11-07-2024
  • KOPN 03-13-2025
  • Dividend Yield
  • ASMB N/A
  • KOPN N/A
  • EPS Growth
  • ASMB N/A
  • KOPN N/A
  • EPS
  • ASMB N/A
  • KOPN N/A
  • Revenue
  • ASMB $28,326,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • ASMB $282.16
  • KOPN $21.40
  • Revenue Next Year
  • ASMB N/A
  • KOPN $14.05
  • P/E Ratio
  • ASMB N/A
  • KOPN N/A
  • Revenue Growth
  • ASMB N/A
  • KOPN 0.60
  • 52 Week Low
  • ASMB $9.84
  • KOPN $0.56
  • 52 Week High
  • ASMB $19.93
  • KOPN $2.82
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 42.21
  • KOPN 71.23
  • Support Level
  • ASMB $14.15
  • KOPN $1.13
  • Resistance Level
  • ASMB $14.95
  • KOPN $2.05
  • Average True Range (ATR)
  • ASMB 0.87
  • KOPN 0.15
  • MACD
  • ASMB -0.12
  • KOPN 0.04
  • Stochastic Oscillator
  • ASMB 8.97
  • KOPN 79.48

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: